New Logo July 12, 2022.png
Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program
30 sept. 2022 18h28 HE | Odyssey Health, Inc
Las Vegas Nevada, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., (the “Company” “Odyssey”) a company focused on developing a unique...
New Logo July 12, 2022.png
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
28 sept. 2022 08h30 HE | Odyssey Health, Inc
Las Vegas, Nevada, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
Cambridge Isotope Laboratories, Inc. (CIL) Partners With ISOtopic Solutions to Release the New Stable Isotope-Labeled and Unlabeled Crude Lipid Yeast Extracts
26 sept. 2022 15h16 HE | Cambridge Isotope Laboratories
TEWKSBURY, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Cambridge Isotope Laboratories, Inc. (CIL) has partnered with ISOtopic Solutions to release the new stable isotope-labeled and unlabeled Crude...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces Results of Phase 2 Study of Lasofoxifene vs. Fulvestrant in Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer and an ESR1 Mutation
13 sept. 2022 09h00 HE | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
22157.jpg
Japan Biotech Startups Directory 2022: Establishment, Technology, Patents, R&D Projects, Investors, Capital Policy, Management Team
05 sept. 2022 07h53 HE | Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "The Directory of Biotech Startups in Japan 2021-2022" directory has been added to ResearchAndMarkets.com's offering. This report is a directory of...
Glycomics Global Market to Reach $3.22 Billion by 2028
02 sept. 2022 08h33 HE | Research and Markets
Dublin, Sept. 02, 2022 (GLOBE NEWSWIRE) -- The "Glycomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product; Application; End User and Geography" report has been added to ...
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board
23 août 2022 09h00 HE | Isracann Biosciences Inc.
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
New Logo July 12, 2022.png
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
18 août 2022 08h00 HE | Odyssey Health, Inc
Las Vegas, NV, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) Announces ‘Dr. Finance Live’ Interview with NFL Hall of Famer Brett Favre and Odyssey Health Inc.’s Dr. Jacob VanLandingham
16 août 2022 08h00 HE | InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN, a multifaceted financial news and publishing company for private and public entities, today announces that NFL Hall of Famer...
MAKO Medical Launches ASPT Accredited Phlebotomy Program
15 août 2022 17h23 HE | MAKO Medical
RALEIGH, N.C., Aug. 15, 2022 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national full service reference laboratory and national leader in COVID-19 testing, today announced the company’s...